Back to Top Skip to main content Skip to sub-navigation

DHA leaders recognize CCP collection campaign contributors & donors

Three military personnel in uniform, wearing masks, in front of flags Deputy Secretary of Defense David L. Norquist (left) and Army Lt. Gen. Ronald J. Place (right) present an award to Air Force Tech. Sgt. Christina Swope on behalf of all Air Force personnel who worked on convalescent plasma efforts during the COVID-19 pandemic. (Photo by Navy Communication Specialist 2nd Class Kurtis A. Hatcher.)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | COVID-19 Vaccine Toolkit | Armed Services Blood Program

Top Department of Defense leaders came together to recognize individuals and teams across the DoD for their effort in meeting the department’s goal of collecting 10,000 units of COVID-19 convalescent plasma (CCP) by September 30.

Deputy Secretary of Defense David Norquist, Assistant Secretary of Defense for Health Affairs Tom McCaffery; and Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency, hosted a recognition ceremony at Walter Reed National Military Medical Center in Bethesda, Maryland, for the individuals and teams that met the goal set by then Secretary of Defense Mark Esper.

“Your success can be attributed to the many hands that worked together to deliver immediate care,” Norquist said during his keynote address. “I congratulate you for achieving thousands of units in such a short amount of time — that is no small feat. It is a testament to your hard work to collect daily collections of at blood donor centers and your willingness to venture into hot spots for mobile blood drives. It would also not be possible without the generosity of approximately 3,000 donors who participated in this campaign.”

On June 1, DHA launched donation drives through its 20 Armed Services Blood Program centers across the continental United States and in Hawaii, Guam, and Germany to collect plasma from patients who have fully recovered from COVID-19 to support the development of an effective treatment against the disease. By the September deadline, DoD had exceeded the goal, obtaining 10,745 total units of procured and donated CCP from active-duty personnel, military retirees, their families, and non-DoD civilians.

“Our medical researchers and infectious disease specialists in this country went to work to understand the disease and what possible treatments we could develop to counter it,” said McCaffery in his opening remarks. “And that is where all of you came in, once again, bringing your expertise and your skills to bear to help offer a life-saving treatment – convalescent plasma – in the middle of a global pandemic,” he added before introducing the deputy secretary of defense.

Group of military personnel around a technician, looking at a computer screen
The Honorable David L. Norquist, Deputy Secretary of Defense; the Honorable Thomas P. McCaffery, the Assistant Secretary of Defense for Health Affairs; and Lieutenant General Ronald J. Place, MC, USA Director, Defense Health Agency toured the Walter Reed National Military Medical Center (WRNMMC) Apheresis Center. (U.S. Navy photo by Mass Communication Specialist 2nd Class Kurtis A. Hatcher/Released)

The immune system of a COVID-19-positive patient creates infection-fighting antibodies contained in their plasma, or the liquid part of their blood. By donating blood, a patient who recovers fully can provide CCP rich in antibodies that can subsequently be transfused into a sick patient who is still fighting the virus to boost their immune system and help them recover.

“Today we gather to acknowledge your selfless act of volunteerism to collect or donate COVID convalescent plasma,” said Norquist. “Thanks to the hard work of the Defense Health Agency to synchronize this worldwide campaign, 160 patients within the Military Health System have received 250 units of plasma. That is 160 lives that you have affected.”

In his closing remarks, Place also congratulated the recipients for their contributions and highlighted that it was a team effort.

“Like every aspect of military medicine, the DHA and the Armed Service Blood Program draw from the expertise of the Army, Navy and Air Force leaders,” he said. “This was a shared success of everyone in military medicine.”

This success reflects the strength of that teamwork, according to Place.

“In my opinion, that’s the best kind of outcome for our health system,” he said. “The reforms to military medicine that Secretary Norquist and Secretary McCaffery are leading remain inspired by the belief that a well-integrated organization across functions, across military departments, and unified in its strategic execution, both internally and with our partners in civilian medicine, strengthens the health and readiness of our force.”

The DoD’s primary goals against the pandemic are to protect its people, maintain readiness, and support the national COVID-19 response. In addition to aiding in the development of new therapeutic treatments for COVID-19-positive patients in DoD facilities, CCP contributes to the overall efforts to combat the disease, thus helping accomplish each of those goals.

“On behalf of the healthcare team, I ask that every donor accept our thanks for their sacrifice — of blood, of plasma, of time, and even a little bit of pain — in order to help someone else,” concluded Place.

Even though the goal has been reached, DoD’s CCP collection effort is ongoing and recovered patients are encouraged to continue donating.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Guidance Regarding Zika Dengue and Chikungunya Viruses

Policy

This guidance contains information about the potential for transfusion-transmitted Zika infection; recommends facilitating donor self-deferral of 28 days after travel to Mexico, the Caribbean, Central America and South America.

DoD Directive 6000.12E: Health Service Support

Policy

This directive designates the Secretary of the Army as the DoD Executive Agent for the Armed Services Blood Program Office (ASBPO) (Reference (h)), who exercises this authority through the Surgeon General of the Army, in accordance with DoDD 5101.1 (Reference (d)).

DoD Instruction 6480.04: Armed Services Blood Program Operational Procedures

Policy

This instruction assign responsibilities, and prescribe procedures to carry out the responsibilities of the Armed Services Blood Program (ASBP) during peacetime, contingency, and wartime operations.

Showing results 1 - 13 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.